114 related articles for article (PubMed ID: 38677743)
21. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma.
Liu F; Wen T; Tang Q; Chen F; Liao D
Nephron; 2020; 144(5):255-260. PubMed ID: 32182617
[TBL] [Abstract][Full Text] [Related]
22. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma.
Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Ji HX; Hsiao CL; Bau DT
Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124
[TBL] [Abstract][Full Text] [Related]
23. The Contribution of Matrix Metalloproteinase-7 Promoter Genotypes to Hepatocellular Carcinoma Susceptibility.
Yueh TC; Tsao HY; Chien WC; Tsai CW; Pei JS; Wu MH; Chen CP; Chen CC; Wang ZH; Mong MC; Yang YC; Hung YC; Bau DT; Chang WS
Anticancer Res; 2022 Nov; 42(11):5275-5282. PubMed ID: 36288882
[TBL] [Abstract][Full Text] [Related]
24. Contribution of Matrix Metalloproteinase-2 Genotypes to Taiwan Pterygium Risk.
Hu PS; Hsia NY; Wang ZH; Chen HC; Hsia TC; Lin ML; Wang YC; Chang WS; Bau DT; Tsai CW
In Vivo; 2024; 38(2):539-545. PubMed ID: 38418145
[TBL] [Abstract][Full Text] [Related]
25. Association of
Fu CK; Mong MC; Yu CC; Yang MD; Wang ZH; Yang YC; Chen JC; Pei JS; Hsia NY; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2022 Apr; 42(4):1749-1755. PubMed ID: 35346993
[TBL] [Abstract][Full Text] [Related]
26. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
[TBL] [Abstract][Full Text] [Related]
27. Monocyte chemotactic protein-1 and CC chemokine receptor 2 polymorphisms and prognosis of renal cell carcinoma.
Liu GX; Zhang X; Li S; Koiiche RD; Sindsceii JH; Song H
Tumour Biol; 2013 Oct; 34(5):2741-6. PubMed ID: 23657965
[TBL] [Abstract][Full Text] [Related]
28. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
29. Association of Matrix Metalloproteinase-7 Genotypes with the Risk of Bladder Cancer.
Liao CH; Chang WS; Tsai CW; Hu PS; Wu HC; Hsu SW; Chen GL; Yueh TC; Shen TC; Hsia TC; Bau DT
In Vivo; 2018; 32(5):1045-1050. PubMed ID: 30388078
[TBL] [Abstract][Full Text] [Related]
30. The Contribution of
Chen GL; Shen TC; Chang WS; Tsai CW; Li HT; Chuang CL; Lai YL; Yueh TC; Hsia TC; Wang SC; Bau DT
Anticancer Res; 2018 Oct; 38(10):5671-5677. PubMed ID: 30275186
[TBL] [Abstract][Full Text] [Related]
31. Association of Matrix Metalloproteinase-9 rs3918242 Promoter Genotypes With Colorectal Cancer Risk.
Wu MH; Tzeng HE; Wu CN; Yueh TC; Peng YC; Tsai CH; Wang YC; Ke TW; Pei JS; Chang WS; Tsai CW; Bau DT
Anticancer Res; 2019 Dec; 39(12):6523-6529. PubMed ID: 31810917
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
Awakura Y; Ito N; Nakamura E; Takahashi T; Kotani H; Mikami Y; Manabe T; Kamoto T; Habuchi T; Ogawa O
Cancer Lett; 2006 Sep; 241(1):59-63. PubMed ID: 16466849
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
34. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
35. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT
Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329
[TBL] [Abstract][Full Text] [Related]
36. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma.
Hirata H; Naito K; Yoshihiro S; Matsuyama H; Suehiro Y; Hinoda Y
Int J Cancer; 2003 Sep; 106(3):372-4. PubMed ID: 12845675
[TBL] [Abstract][Full Text] [Related]
37. Association of Matrix Metalloproteinase-7 Genotypes With Prostate Cancer Risk.
Liao CH; Chang WS; Hsu WL; Hu PS; Wu HC; Hsu SW; Wang BR; Yueh TC; Chen CH; Hsia TC; Huang WC; Bau DT; Tsai CW
Anticancer Res; 2023 Jan; 43(1):381-387. PubMed ID: 36585199
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population.
Wang Z; Xu Y; Zhu S
Int J Clin Exp Pathol; 2015; 8(11):15228-33. PubMed ID: 26823871
[TBL] [Abstract][Full Text] [Related]
39. Contribution of Matrix Metallopeptidase-1 Genotypes, Smoking, Alcohol Drinking and Areca Chewing to Nasopharyngeal Carcinoma Susceptibility.
Tsai CW; Chang WS; Gong CL; Shih LC; Chen LY; Lin EY; Li HT; Yen ST; Wu CN; Bau DT
Anticancer Res; 2016 Jul; 36(7):3335-40. PubMed ID: 27354591
[TBL] [Abstract][Full Text] [Related]
40. The Contribution of
Yueh TC; Wu CN; Hung YW; Chang WS; Fu CK; Pei JS; Wu MH; Lai YL; Lee YM; Yen ST; Li HT; Tsai CW; Bau DT
Cancer Genomics Proteomics; 2018; 15(3):207-212. PubMed ID: 29695403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
